BIO-key International (NASDAQ:BKYI) Share Price Crosses Below 200 Day Moving Average – Here’s What Happened

BIO-key International Inc. (NASDAQ:BKYI) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.72 and traded as low as $0.6738. BIO-key International shares last traded at $0.72, with a volume of 3,958,363 shares traded.

Wall Street Analyst Weigh In

BKYI has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of BIO-key International to a “sell” rating in a report on Saturday, January 3rd. One analyst has rated the stock with a Sell rating, According to MarketBeat, BIO-key International has a consensus rating of “Sell”.

BIO-key International Trading Down 8.7%

The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13. The business has a 50-day simple moving average of $0.62 and a two-hundred day simple moving average of $0.72. The stock has a market cap of $7.13 million, a price-to-earnings ratio of -0.63 and a beta of 0.41.

Institutional Investors Weigh In On BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC raised its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Institutional investors and hedge funds own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.